Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.

Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.

Lipid-lowering drugs are used for the prevention of cardiovascular diseases. Statins are the most commonly used lipid-lowering drugs. Evidence from preclinical and observational studies suggests that statins might improve the prognosis of breast cancer patients. We analyzed data from the German MARI...

Full description

Bibliographic Details
Main Authors: Stefan Nickels, Alina Vrieling, Petra Seibold, Judith Heinz, Nadia Obi, Dieter Flesch-Janys, Jenny Chang-Claude
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3783471?pdf=render

Internet

http://europepmc.org/articles/PMC3783471?pdf=render

Similar Items